{"id":"W2231288659","doi":"10.1016/j.annder.2015.10.104","title":"Ixekizumab dans le traitement du psoriasis en plaques modéré à sévère : résultats à 60 semaines d’une étude de phase 3, en double aveugle, avec une phase d’induction suivie d’une phase de re-randomisation (UNCOVER-1)","year":2015,"lang":"fr","type":"article","venue":"Annales de Dermatologie et de Vénéréologie","topic":"Psoriasis: Treatment and Pathogenesis","field":"Immunology and Microbiology","cited_by":0,"is_retracted":false,"has_abstract":false,"ca_institutions":"Dalhousie University","funders":"","keywords":"Medicine; Ixekizumab; Gynecology; Psoriasis; Secukinumab; Dermatology","routes":{"ca_aff":true,"ca_fund":false,"ca_venue":false,"about_ca":false,"invisible_to_affiliation_only":false},"retraction":null,"screen":null,"direct_labels":[],"prediction":{"model_version":"metacan-v3-hybrid-931329e0061c","candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.003882621,0.0009963424,0.002839138,0.0003337942,0.0003805373,0.0009975885,0.0004666476,0.001164695,0.002210058],"category_scores_gemma":[0.002346723,0.0004855467,0.003658374,0.0003466878,0.0008279613,0.001079639,0.0002674576,0.002486249,0.0004612949],"about_ca_system_candidate":false,"about_ca_system_consensus":false,"about_ca_system_score_codex":0.0007981362,"about_ca_system_score_gemma":0.0006720172,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_topic_score_codex":0.001493524,"about_ca_topic_score_gemma":0.001785849,"domain_scores_codex":[0.9988264,0.0005543454,0.00009904477,0.000190077,0.0001438317,0.000186243],"domain_scores_gemma":[0.9983503,0.0007767425,0.0002905715,0.0002020284,0.0001655686,0.0002147617],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"randomized_trial","study_design_gemma":"randomized_trial","study_design_scores_codex":[0.7083377,0.02339497,0.006146636,0.002422683,0.006109651,0.0002146901,0.0006064157,0.002430956,0.03771199,0.000241544,0.002145915,0.2102368],"study_design_scores_gemma":[0.4720334,0.4761057,0.03083327,0.0002608897,0.005217361,0.0005483484,0.0001940048,0.001681878,0.008166078,0.0003960714,0.004464793,0.00009836831],"study_design_candidate":"randomized_trial","study_design_consensus":"randomized_trial","genre_codex":"empirical","genre_gemma":"empirical","genre_scores_codex":[0.9805045,0.01657712,0.0007662506,0.0003189937,0.000158336,0.0004213052,0.0003902312,0.00004735565,0.0008158041],"genre_scores_gemma":[0.9884067,0.00698189,0.001269238,0.0005383447,0.0002340264,0.0004330123,0.0006970636,0.0000399219,0.001399786],"genre_candidate":"empirical","genre_consensus":"empirical","teacher_disagreement_score":0.003882621,"threshold_uncertainty_score":0.0205335,"prediction_status":"machine_predicted_unvalidated"},"machine_scores":{"provisional":true,"baseline":true,"maturity_gate_passed":false,"score_opus":0.05384061089742038,"score_gpt":0.3292670785092376,"score_spread":0.2754264676118173,"validation_status":"score_only:v0-immature-baseline","note":"Baseline scores from an immature model (maturity gate not passed). Scores rank; they never assert a category."}}